Sexually transmitted diseases diagnostics sales will rise through 2036, driven by laboratory devices at 67.6% of the device segment in 2026. The market was valued at USD 4.63 billion in 2025 and is expected to be worth USD 10.05 billion by 2036, creating an incremental opportunity of USD 5.08 billion.